Kenneth Galbraith

Insider Reports History

Location
Surrey, British Columbia, Canada
Signature
/s/ Daniel Dex, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kenneth Galbraith:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Zymeworks Inc. Chair & CEO, Director Common Stock 133K $3.6M $27.02 22 Dec 2025 Direct
Zymeworks Inc. Chair & CEO, Director Restricted Stock Unit 0 $2.87M $14.92 22 Dec 2025 Direct
MACROGENICS INC Director Stock Option (right to buy) 15K $22.7K $1.51 13 May 2021 Direct
Zymeworks Inc. Chair, President & CEO, Director Stock Option (Right to Buy) 500K 15 Jan 2022 Direct
Zymeworks Inc. Chair & CEO, Director Stock Option (Right to Buy) 288K 10 Jan 2025 Direct

Insider Reports Filed by Kenneth Galbraith

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ZYME Zymeworks Inc. 22 Dec 2025 3 -$1.28M 4 Chair & CEO, Director 22 Dec 2025, 17:52
ZYME Zymeworks Inc. 10 Jan 2025 2 $0 4 Chair & CEO, Director 10 Jan 2025, 17:58
ZYME Zymeworks Inc. 06 Jan 2025 6 -$855K 4 Chair & CEO, Director 06 Jan 2025, 20:34
ZYME Zymeworks Inc. 05 Jan 2024 6 -$258K 4 Chair & CEO, Director 08 Jan 2024, 18:23
ZYME Zymeworks Inc. 05 Jan 2023 2 $0 4 Chair & CEO, Director 06 Jan 2023, 19:00
ZYME Zymeworks Inc. 22 Dec 2022 1 $0 4 Chair & CEO, Director 23 Dec 2022, 18:30
ZYME Zymeworks Inc. 15 Jan 2022 1 $0 4 Chair, President & CEO, Director 18 Jan 2022, 05:25
ZYME Zymeworks Inc. 15 Jan 2022 0 $0 3 Chair, President & CEO, Director 18 Jan 2022, 05:20
MGNX MACROGENICS INC 13 May 2021 1 $0 4 Director 17 May 2021, 21:20